GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Well Shardster almost everything iv'e said has come true, thing deep down you know yourself Motif is almost done, its just a matter of time now.....
I'm going to say it will close around 0.4 - 0.45 tomorrow
Your post from today below, why would a company with a potential covid play want to pair up with Motif who have a few peanuts in the bank, imo i think this will just drag on until suspension then delisting....
BF - 452 posts on this BB. You know how covid could impact this cash shell. From the RNS:
The Company is in negotiations with several RTO candidates in the healthcare sector. The Covid-19 pandemic has created new opportunities for companies in the healthcare sector and the RTO candidates under current consideration are exploring ways in which their therapeutic product candidates may help patients with Covid-19.
Clearly states how covid COULD impact this cash shell. But you know that, had many discussions about it - after all you love a good RNS copy and paste. Your goal is to sow seeds of doupt in to people's minds.
Not great news, think it might hit the placing price tomorrow now iclaprim is off the table (as i said) i'll be surprised if a RTO now even happens IMO but GL
Not a great finish to the day SP wise, said this would carry on drifting and i was right yet again, also only 25 trading days to go until the 28th of July unless ext is granted before potential suspension, but GL
Yeah i agree covid could be around for a while, but how will that impact Motif when they are just a cash shell...
Delay in publication of Final Results
Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM Rule 15 cash shell, announces that though the audit process for 2019 has commenced, there will be a delay in the publication of the Company's audited financial results for the year ended 31 December 2019 (the "Final Results") as a result of the Covid-19 pandemic (the "Pandemic"). As such, Motif has requested and received an extension to its filing deadline for the Company's Final Results from 30 June 2020 to 30 September 2020.
Motif has appointed Crowe U.K. LLP ("Crowe") to replace Pricewaterhouse Coopers LLP as their auditor. The Pandemic has led to delays in the process of Crowe's appointment and the timing for the completion of the audit.
Following its reclassification as an AIM Rule 15 cash shell in January 2020, the Company is required to make an acquisition which constitutes a reverse takeover under the AIM Rules by 28 July 2020, failing which the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40. The Company's admission to trading on AIM would then be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
You've got to take your hat off to Lombard bought in cheap then made 100% to 150% and then got out, well done to them....
Selling @ 0.60 and 0.55 agree with your post Doyezee....
Morning everyone, delayed results eh, makes you wonder what these people are doing with so much time on their hands, just blame covid for everything
Morning everyone, hope everyone is well today
Consistent with the resolutions passed at the General Meeting, the Company is granting to Hercules warrants over 24,267,408 ordinary shares and warrants over 97,069,633 ordinary shares which aggregate to 121,337,041 ordinary shares of 0.01 pence ("Ordinary Shares"), representing a total of 25 per cent of the Company's outstanding share capital (the "Hercules Warrants"). The Hercules Warrants will expire on 27 January 2025 and have an exercise price of 0.42 pence, which is consistent with the placing price of the Company's Conditional Placing, which was announced on 2 October 2019.
Read the RNS i have posted, they have been saying the same thing over and over and over again
RNS from 4th May
Current Financial Position
The Directors of Motif Bio have continued to impose disciplined cost controls, with the Company maintaining very limited operations. As a result, Motif Bio's cash balance is approximately £0.23 million as at 4 May 2020, which has allowed the Company's cash runway to be extended into June.
The Company's Directors remain focused on sourcing an appropriate reverse takeover candidate for Motif Bio. The Company is required to make an acquisition which constitutes a reverse takeover under the AIM Rules by 28 July 2020, failing which the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40. The Company's admission to trading on AIM would then be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified. At present, no assurances can be given that the efforts to source and/or complete a reverse takeover transaction will be successful.
RNS from 18th March
Following reclassification, the Company is required to make an acquisition which constitutes a reverse takeover under the AIM Rules by 28 July 2020, failing which the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40. The Company's admission to trading on AIM would then be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified.
The Company's Directors remain focused on sourcing an appropriate reverse takeover candidate for Motif Bio and this search continues. At present, no assurances can be provided that the effort will be successful to source and/or complete a reverse takeover transaction. The Company's Directors will provide shareholders with further updates as appropriate.
The Company currently has sufficient working capital into May 2020. As such, the Directors continue to impose disciplined cost controls and the Company is maintaining very limited operations.
From RNS 28th of January
Current Financial Position
Motif Bio's cash balance was approximately £0.4 million as at 27 January 2020 and the Company currently has sufficient working capital to May 2020. As such, the Directors continue to impose disciplined cost controls and the Company is maintaining very limited operations.
Take it you have not done what you said and read all the RNS, they have said numerous times they have sufficient working capital until ???????, then close to when they are running out of capital they have raised more money, if you want me to post them i will.
So each time they have raised money it has gone on salaries
Norsetaw i have heard it all now, i really have......
Truth is not me and i am not him he has he's views and i have mine and even if that was the case (which it is not) if you think one person can move this share price, you really should not be investing in shares.....
As for Steadydanny, why are you angry that he bought shares at 0.29 and then took his stake back, sounds like you bought high and are now angry that you are underwater, good luck to him i say......
On how much money you have to invest and how much profit you are happy to make
LOL my pugs think they are all better sticking their money on the favourite in the 3.30 @ Ascot....
Look its a flip of the coin and i think you have done the sensible thing.......